ABVC BioPharma, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$204.22 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12
- ABVC BioPharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$107.62K, a 246.15% decline year-over-year.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$96.60K, a 64931.54% decline year-over-year.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$4.41K, a 101.66% decline year-over-year.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $2.28K.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $71.65K.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$12.95K.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$101.93K.
- ABVC BioPharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$238.09K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$107.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$204.22K 10-Q · filed 2026-08-12 | -$208.63K derived: sum of 3 quarters · filed 2026-08-12 | -$206.35K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$96.60K 10-Q · filed 2026-05-18 | -$101.01K derived: sum of 2 quarters · filed 2026-05-18 | -$98.73K derived: sum of 3 quarters · filed 2026-05-18 | -$25.09K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$4.41K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | -$2.13K derived: sum of 2 quarters · filed 2026-03-03 | $71.50K derived: sum of 3 quarters · filed 2026-08-12 | $71.65K 10-K · filed 2026-03-03 | |
| 2025-09-30 | $2.28K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $75.92K derived: sum of 2 quarters · filed 2026-08-12 | $76.07K 10-Q/A · filed 2026-03-03 | $341.85K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $73.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $73.79K 10-Q · filed 2026-08-12 | $339.57K derived: sum of 3 quarters · filed 2026-08-12 | $141.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $149.00 10-Q · filed 2026-05-18 | $265.93K derived: sum of 2 quarters · filed 2026-05-18 | $67.36K derived: sum of 3 quarters · filed 2026-05-18 | -$66.18K derived: sum of 4 quarters · filed 2026-05-18 | |
| 2024-12-31 | $265.79K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $67.21K derived: sum of 2 quarters · filed 2026-03-03 | -$66.33K derived: sum of 3 quarters · filed 2026-03-03 | -$12.95K 10-K · filed 2026-03-03 | |
| 2024-09-30 | -$198.57K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | -$332.11K derived: sum of 2 quarters · filed 2026-03-03 | -$278.73K 10-Q/A · filed 2026-03-03 | ||
| 2024-06-30 | -$133.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$80.16K 10-Q · filed 2025-08-13 | -$7.25K 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | $53.38K 10-Q · filed 2025-04-30 | ||||
| 2023-12-31 | -$101.93K 10-K · filed 2024-03-13 | ||||
| 2023-06-30 | -$204.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$720.00 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $203.62K 10-Q · filed 2024-05-17 | ||||
| 2022-12-31 | -$238.09K 10-K · filed 2024-03-13 |